ARDX
Ardelyx Inc
Price:  
5.22 
USD
Volume:  
2,123,599.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-173.4%
Upside

As of 2024-12-15, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -21.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,289.64 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -59.33 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.4x - 15.1x 13.8x
Forward P/E multiples 13.4x - 15.3x 15.0x
Fair Price (3.58) - (4.00) (3.83)
Upside -168.5% - -176.6% -173.4%
5.22 USD
Stock Price
(3.83) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -22.14
2024-12-10 -21.94
2024-12-09 -21.94
2024-12-06 -23.73
2024-12-05 -22.85
2024-12-04 -23.17
2024-12-03 -22.85
2024-12-02 -23.01
2024-11-29 -23.53
2024-11-27 -23.61
2024-11-26 -22.26
2024-11-25 -21.86
2024-11-22 -22.10
2024-11-21 -21.34
2024-11-20 -20.54
2024-11-19 -20.02
2024-11-18 -20.70
2024-11-15 -20.74
2024-11-14 -19.70
2024-11-13 -18.86
2024-11-12 -19.22
2024-11-11 -20.44
2024-11-08 -21.14
2024-11-07 -26.37
2024-11-06 -26.81
2024-11-05 -23.73
2024-11-04 -24.41
2024-11-01 -25.21
2024-10-31 -24.33
2024-10-30 -24.41
2024-10-29 -24.89
2024-10-28 -24.45
2024-10-25 -23.93
2024-10-24 -24.29
2024-10-23 -23.17
2024-10-22 -23.97
2024-10-21 -24.37
2024-10-18 -24.21
2024-10-17 -24.17
2024-10-16 -24.25
2024-10-15 -24.73
2024-10-14 -24.81
2024-10-11 -25.01
2024-10-10 -25.01
2024-10-09 -24.33
2024-10-08 -24.69
2024-10-07 -25.37
2024-10-04 -28.12
2024-10-03 -27.49
2024-10-02 -28.56